Literature DB >> 24952929

Cost analysis of periprocedural imaging in patients undergoing catheter ablation for atrial fibrillation.

Sean D Pokorney1, Bradley G Hammill2, Laura G Qualls2, Benjamin A Steinberg1, Lesley H Curtis2, Jonathan P Piccini3.   

Abstract

Cardiovascular imaging is an important part of procedural planning and safety for catheter ablation of atrial fibrillation (AF). However, the costs of imaging surrounding catheter ablation of AF have not been described. Medicare fee-for-service data were used to evaluate Medicare expenditures before, during, and after catheter ablation for AF from July 2007 to December 2009. Among 11,525 patients who underwent catheter ablation for AF, the mean overall expenditure on the day of the procedure was $14,455 (SD $7,441). The mean imaging expenditure in the periprocedural period, which included the 30 days before the catheter ablation and the day of the ablation itself, was $884 (SD $455). Periprocedural imaging expenditures varied by the imaging strategy used, ranging from a mean of $557 (SD $269) for patients with electroanatomic mapping only to $1,234 (SD $461) for patients with electroanatomic mapping, transesophageal echocardiogram, and computed tomography or magnetic resonance imaging. Mean patient-level imaging expenditures varied by provider (mean $872, SD $249). Periprocedural imaging expenditures also varied by patient risk, with mean expenditures of $862 (SD $444) for patients with a CHADS2 score of ≥2 compared with $907 (SD $466) for CHADS2 score<2 (p<0.001). In conclusion, periprocedural imaging accounts for approximately 6% of mean Medicare expenditures for catheter ablation of AF. The expenditures for periprocedural imaging vary both at the patient and at the provider level and they are inversely related to stroke risk by CHADS2 score.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24952929      PMCID: PMC4090097          DOI: 10.1016/j.amjcard.2014.04.031

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  22 in total

1.  Integrated electroanatomic mapping with three-dimensional computed tomographic images for real-time guided ablations.

Authors:  Jun Dong; Hugh Calkins; Stephen B Solomon; Shenghan Lai; Darshan Dalal; Albert C Lardo; Al Lardo; Erez Brem; Assaf Preiss; Ronald D Berger; Henry Halperin; Timm Dickfeld
Journal:  Circulation       Date:  2006-01-09       Impact factor: 29.690

2.  Health insurers and medical-imaging policy--a work in progress.

Authors:  John K Iglehart
Journal:  N Engl J Med       Date:  2009-03-05       Impact factor: 91.245

3.  Electrical isolation of pulmonary veins in patients with atrial fibrillation: reduction of fluoroscopy exposure and procedure duration by the use of a non-fluoroscopic navigation system (NavX).

Authors:  Heidi Luise Estner; Isabel Deisenhofer; Armin Luik; Gjin Ndrepepa; Christian von Bary; Bernhard Zrenner; Claus Schmitt
Journal:  Europace       Date:  2006-07-10       Impact factor: 5.214

4.  Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation.

Authors:  Jonathan P Piccini; Moritz F Sinner; Melissa A Greiner; Bradley G Hammill; João D Fontes; James P Daubert; Patrick T Ellinor; Adrian F Hernandez; Allan J Walkey; Susan R Heckbert; Emelia J Benjamin; Lesley H Curtis
Journal:  Circulation       Date:  2012-09-26       Impact factor: 29.690

5.  Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.

Authors:  Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali
Journal:  Med Care       Date:  2005-11       Impact factor: 2.983

6.  Dual-enhancement cardiac computed tomography for assessing left atrial thrombus and pulmonary veins before radiofrequency catheter ablation for atrial fibrillation.

Authors:  Jin Hur; Hui-Nam Pak; Young Jin Kim; Hye-Jeong Lee; Hyuk-Jae Chang; Yoo Jin Hong; Byoung Wook Choi
Journal:  Am J Cardiol       Date:  2013-04-11       Impact factor: 2.778

7.  Contrast-enhanced CMR is equally effective as TEE in the evaluation of left atrial appendage thrombus in patients with atrial fibrillation undergoing pulmonary vein isolation procedure.

Authors:  Vikas K Rathi; Sahadev T Reddy; Sandeep Anreddy; William Belden; June A Yamrozik; Ronald B Williams; Mark Doyle; Diane V Thompson; Robert W W Biederman
Journal:  Heart Rhythm       Date:  2013-02-27       Impact factor: 6.343

8.  Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation.

Authors:  Elena Birman-Deych; Martha J Radford; David S Nilasena; Brian F Gage
Journal:  Stroke       Date:  2006-03-09       Impact factor: 7.914

9.  Intracardiac echocardiography for detection of thrombus in the left atrial appendage: comparison with transesophageal echocardiography in patients undergoing ablation for atrial fibrillation: the Action-Ice I Study.

Authors:  Jakub Baran; Sebastian Stec; Ewa Pilichowska-Paszkiet; Beata Zaborska; Małgorzata Sikora-Frąc; Tomasz Kryński; Ilona Michałowska; Rafał Łopatka; Piotr Kułakowski
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-11-15

10.  Physician-controlled costs: the choice of equipment used for atrial fibrillation ablation.

Authors:  Roger A Winkle; R Hardwin Mead; Gregory Engel; Melissa H Kong; Rob A Patrawala
Journal:  J Interv Card Electrophysiol       Date:  2013-03-14       Impact factor: 1.900

View more
  2 in total

1.  The use of cardiac-CT alone to exclude left atrial thrombus before atrial fibrillation ablation: Efficiency, safety, and cost analysis.

Authors:  Wassim Mosleh; Ali Sheikh; Zaid Said; Mohamed Abdel-Aal Ahmed; Siri Gadde; Tanvi Shah; Michael F Wilson; Hiroko Beck; Chee Kim; Umesh C Sharma
Journal:  Pacing Clin Electrophysiol       Date:  2018-06-04       Impact factor: 1.976

2.  Cardiac Tomography and Cardiac Magnetic Resonance to Predict the Absence of Intracardiac Thrombus in Anticoagulated Patients Undergoing Atrial Fibrillation Ablation.

Authors:  Fatima Zaraket; Deva Bas; Jesus Jimenez; Benjamin Casteigt; Begoña Benito; Julio Martí-Almor; Javi Conejos; Helena Tizón-Marcos; Diana Mojón; Ermengol Vallès
Journal:  J Clin Med       Date:  2022-04-08       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.